tiprankstipranks
Analyst Profile
Followed by 53 other investors
.
Yun Zhong

Yun Zhong

BTIG
Wall Street Analyst
Ranked #7,679 out of 8,047 Analysts on TipRanks (#20,427 out of 21,521 overall experts)

Success Rate

39%
43 out of 111 Profitable Transactions

Average Return

-9.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Yun Zhong's ratings since 2018 and opened each position for the duration of 1 Year:
38.74% of your transactions would have been profitable with an average return of -9.5%

Stock Rating Distribution

139Ratings
86.33% Buy
13.67% Hold
0.00% Sell
Distribution of Yun Zhong's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Mereo Biopharma
(MREO)
Rating Type:Buy
Dates:May 09, 2022 - Jan 01, 1970
Gain:237.50%
The most profitable rating made by Yun Zhong

Yun Zhong's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
Summit Therapeutics
Jun 28, 2018
Hold
Downgraded
0%
-82.60%
3
Denali Therapeutics
Nov 12, 2018
Buy
Initiated
0%
-9.80%
1
Bluebird Bio
Dec 03, 2018
Buy
Reiterated
$170.00
(2429.76% Upside)
0%
-33.85%
3
NITE
Nightstar Therapeutics Limited
Mar 05, 2019
Hold
Downgraded
100%
+30.10%
2
INSYQ
Insys Therapeutics
May 14, 2019
Hold
Downgraded
0%
-73.50%
4
NTRP
Neurotrope Inc
Sep 11, 2019
Hold
Downgraded
0.00%
1
Global Blood Therapeutics
Nov 26, 2019
Buy
Reiterated
$90.00
(34.83% Upside)
50%
-1.65%
2
Eloxx Pharmaceuticals
Feb 04, 2020
Buy
Reiterated
$14.00
(4207.69% Upside)
0%
-33.25%
2
Y-Mabs Therapeutics
May 01, 2020
Buy
Initiated
0%
-7.10%
1
Marker Therapeutics
May 12, 2020
Buy
Reiterated
$10.00
(2440.65% Upside)
0%
-44.83%
3
List of latest recommendations made by Yun Zhong. Click to expand and see Yun Zhong's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More